Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haifa Hassanie

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|December 25, 2024
SETDB1: an emerging target for anticancer drug developmentGustavo Henrique Goulart Trossini, Haifa Hassanie, André Berndt Penteado, et al.
Future Medicinal Chemistry|March 9, 2023
Human sirtuin 2 inhibitors, their mechanisms and binding modesAndré Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, et al.
Scientific Reports|December 8, 2022
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicityDorival Mendes Rodrigues-Junior, Cristiano Raminelli, Haifa Hassanie, et al.
RSC Medicinal Chemistry|May 27, 2024
SETDB1 as a cancer target: challenges and perspectives in drug designHaifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|December 25, 2024
SETDB1: an emerging target for anticancer drug developmentGustavo Henrique Goulart Trossini, Haifa Hassanie, André Berndt Penteado, et al.
Future Medicinal Chemistry|March 9, 2023
Human sirtuin 2 inhibitors, their mechanisms and binding modesAndré Berndt Penteado, Haifa Hassanie, Renan Augusto Gomes, et al.
Scientific Reports|December 8, 2022
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicityDorival Mendes Rodrigues-Junior, Cristiano Raminelli, Haifa Hassanie, et al.
RSC Medicinal Chemistry|May 27, 2024
SETDB1 as a cancer target: challenges and perspectives in drug designHaifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
Pageof 1